Myelin Protein Zero-Like 2 (MPZL2) Peptide
MPZL2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all MPZL2 products
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- LEAVNGTDAR LKCTFSSFAP VGDALTVTWN FRPLDGGPEQ FVFYYHIDPF
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MPZL2 antibody,
Alternative Names: MPZL2 control peptide, MPZL2 antibody Blocking Peptide, Anti-MPZL2 Blocking Peptide, Myelin Protein Zero-Like 2 Blocking Peptide, EVA Blocking Peptide, EVA1 Blocking Peptide, MPZL2, MPZL-2, MPZL 2, MPZL-2 Blocking Peptide, MPZL 2 Blocking Peptide - Purification
- Rabbit Anti-Tau (Ab-396) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- MPZL2 (Myelin Protein Zero-Like 2 (MPZL2))
- Background
- Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis.
- Molecular Weight
- 22 kDa
-
You are here:
